Recent advances and new concepts for the synthesis of axially stereoenriched biaryls von Wencel-Delord, J, Panossian, A, Leroux, F. R, Colobert, F

Volltext

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study von Hansen, A.R., Massard, C., Ott, P.A., Haas, N.B., Lopez, J.S., Ejadi, S., Wallmark, J.M., Keam, B., Delord, J.-P., Aggarwal, R., Gould, M., Yang, P., Keefe, S.M., Piha-Paul, S.A.

Volltext

Mild metal-catalyzed C-H activation: examples and concepts von Gensch, T, Hopkinson, M. N, Glorius, F, Wencel-Delord, J

Volltext

CNRS Silver Medals:D. Farrusseng, E. Collet, andP. Poulin / CNRS Bronze Medals:J. Wencel‐Delord and D. Voiry von Farrusseng, D., Collet, Eric, Poulin, Philippe, Wencel-Delord, J., Voiry, Damien

Volltext

A remarkable solvent effect of fluorinated alcohols on transition metal catalysed C–H functionalizations von Wencel-Delord, J., Colobert, F.

Volltext

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macroph... von Gomez-Roca, C.A., Italiano, A., Le Tourneau, C., Cassier, P.A., Toulmonde, M., D’Angelo, S.P., Campone, M., Weber, K.L., Loirat, D., Cannarile, M.A., Jegg, A.-M., Ries, C., Christen, R., Meneses-Lorente, G., Jacob, W., Klaman, I., Ooi, C.-H., Watson, C., Wonde, K., Reis, B., Michielin, F., Rüttinger, D., Delord, J.-P., Blay, J.-Y.

Volltext

Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer—results of a first-in-man dose-escalation study with a fixed-dose extension... von Isambert, N., Delord, J.-P., Soria, J.-C., Hollebecque, A., Gomez-Roca, C., Purcea, D., Rouits, E., Belli, R., Fumoleau, P.

Volltext

Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation von Castells, M, Milhas, D, Gandy, C, Thibault, B, Rafii, A, Delord, J-P, Couderc, B

Volltext

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck von Mesía, R., Rivera, F., Kawecki, A., Rottey, S., Hitt, R., Kienzer, H., Cupissol, D., De Raucourt, D., Benasso, M., Koralewski, P., Delord, J.-P., Bokemeyer, C., Curran, D., Gross, A., Vermorken, J.B.

Volltext

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analy... von Belin, L., Kamal, M., Mauborgne, C., Plancher, C., Mulot, F., Delord, J.-P., Gonçalves, A., Gavoille, C., Dubot, C., Isambert, N., Campone, M., Trédan, O., Ricci, F., Alt, M., Loirat, D., Sablin, M.-P., Paoletti, X., Servois, V., Le Tourneau, C.

Volltext

Stereospecific C–H activation as a key step for the asymmetric synthesis of various biologically active cyclopropanes von Jerhaoui, S, Poutrel, P, J-P Djukic, Wencel-Delord, J, Colobert, F

Volltext

MO01.10 Activity of Lurbinectedin in Second-line SCLC Patients Who Are Candidates for Platinum Rechallenge von Subbiah, V., Paz-Ares, L., Besse, B., Zaman, K., Sala, M.A., López-Vilariño, J.A., Fernández, C., Kahatt, C., Siguero, M., Zeaiter, A., Arrondeau, J., Delord, J.-P., Martínez, M., Antón, A., Trigo, José M., Wannesson, L.

Volltext

The prognostic impact of immune-related adverse events during anti-PD1 treatment in melanoma and non-small-cell lung cancer: a real-life retrospective study von Dupont, R., Bérard, E., Puisset, F., Comont, T., Delord, J.-P., Guimbaud, R., Meyer, N., Mazieres, J., Alric, L.

Volltext

Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast,... von Schöffski, P., Besse, B., Gauler, T., de Jonge, M.J.A., Scambia, G., Santoro, A., Davite, C., Jannuzzo, M.G., Petroccione, A., Delord, J.-P.

Volltext

Pharmacokinetics of heated intraperitoneal oxaliplatin von Ferron, G., Dattez, S., Gladieff, L., Delord, J.-P., Pierre, S., Lafont, T., Lochon, I., Chatelut, E.

Volltext

Adverse skin reactions induced by BRAF inhibitors: a systematic review von Sibaud, V, Lamant, L, Maisongrosse, V, Delord, J-P

Volltext

Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine von Husseini, F., Delord, J.-P., Fournel-Federico, C., Guitton, J., Erbs, P., Homerin, M., Halluard, C., Jemming, C., Orange, C., Limacher, J.-M., Kurtz, J.-E.

Volltext

Iron‐Catalyzed Minisci Type Acetylation of N‐Heteroarenes Mediated by CH(OEt)3/TBHP von Srinivasulu, A., Shantharjun, B., Vani, D., Ashalu, K. Chinna, Mohd, A., Wencel‐Delord, J., Colobert, F., Reddy, K. Rajender

Volltext

Habitat preferences of Phoebetria albatrosses in sympatry and allopatry von Bentley, Lily K., Phillips, Richard A., Carpenter‐Kling, Tegan, Crawford, Robert J. M., Cuthbert, Richard J., Delord, Karine, Dilley, Ben J., Makhado, Azwianewi B., Miller, Peter I., Oppel, Steffen, Pistorius, Pierre A., Ryan, Peter G., Schoombie, Stefan, Weimerskirch, Henri, Manica, Andrea

Volltext

Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio von Thomas, F, Hennebelle, I, Delmas, C, Lochon, I, Dhelens, C, Garnier Tixidre, C, Bonadona, A, Penel, N, Goncalves, A, Delord, JP, Toulas, C, Chatelut, E

Volltext